Publication | Closed Access

Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes

Medicinal ChemistryBiochemistryNatural SciencesPotential Anticancer AgentMolecular BiologySelective DamageAnti-cancer AgentMolecular ComplexTumor TargetingChemical ProbeMedicineRedox BiologyDrug Discovery